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It has been known for more than a
century that two distinct set of chemo-
sensitive mechanisms contribute to human
ventilatory control. This tightly controlled
chemoreflex system operate via a negative
feedback loop, mediating cardiorespiratory
responses, which maintains arterial blood
gases and acid–base balance within
normal limits in a healthy organism
under most circumstances. In contrast,
dysfunctional chemoreflex sensitivity
contributes to abnormal ventilatory
control, turning this mechanism into
a key point in the pathophysiology of
highly prevalent diseases, like chronic
heart failure (CHF), hypertension, chronic
obstructive pulmonary disease (COPD),
and obstructive sleep apnoea (OSA) (Kara
et al. 2003).
Peripherally, the chemoreflex control of
ventilation is mediated by polymodal
receptors (mainly in the carotid body;
CB), which are sensitive to changes in
the concentration of various substances
in the arterial blood, such as carbon
dioxide (CO2), hydrogen ions (H+), lactate,
potassium, glucose, insulin andangiotensin.
However, the major stimulus to peripheral
chemoreceptors is the reduction in partial
pressure of oxygen in the arterial blood
(PaO2 ). Centrally, receptors are located in
manybrainstemareas, including thenucleus
of the solitary tract (NTS), raphe, locus
coeruleus and cerebellar fastigial nucleus.
But, more recently, evidence from Guyenet
et al. (2010) andStornetta et al. (2006) (cited
byDempsey&Smith, 2014) has emphasized
that the retrotrapezoid nucleus (RTN),
which is characterized by glutamatergic
interneurons expressing Phox2b, is the
major potential site of central CO2/H+
chemoresponsiveness.
Despite the existence of separate chemo-
sensitive areas, with different stimulus
characteristics, peripheral and central
chemoreflexes do not act independently
of each other. The discovery of important
sites of convergence between CB and brain-
stem chemoreceptors in the NTS and RTN
supports the idea of peripheral–central
chemoreflex interdependence (Stornetta
et al. 2006; cited by Dempsey & Smith,
2014). However, how these receptors inter-
act to provide coordinated control of
ventilation remains controversial. Previous
studies provided evidence of different forms
of peripheral–central interaction, i.e. (1)
hypoadditive, where the stimulation of one
reflex attenuate the response of the other,
(2) additive, where both reflexes do not
interact in a significant way, or (3) hyper-
additive, where the stimulation of one reflex
results in increased response of the other
(also known as synergism). The controversy
over the nature of this interaction has
been attributed to heterogeneous protocols,
preparations and species involved in pre-
vious studies. For example, some of these
studies included decerebrated, vagotomized
and anaesthetized animals (Day & Wilson,
2009), which is a highly controlled pre-
paration, but could per se reduce the
ventilatory response in face of central
and/or peripheral stimulation or inhibition.
Consequently, it may not reflect the real
ventilatory control of an intact awakeanimal
or human. Others investigated the inter-
action in humans, via non-invasive studies,
which is limited to interpreting the function
of each reflex separately.
Based on the unclear nature of the chemo-
reflexes interaction, Smith et al. (2015)
published a recent study in The Journal
of Physiology using an intricate invasive
preparation in intact, non-anaesthetized,
awake dogs, which allowed independent
peripheral and central stimulation or
inhibition. The left CB was denervated and
the right carotid sinus was prepared with
a vascular occluder and catheter allowing
reversible isolation and extracorporeal
perfusion of the intact CB. Then, the
intact CB was exposed to three different
conditions: (1) normal stimuli to the CB,
with pH, PaO2 and PaCO2 concentrations
matching a given dog’s eupnoeic values; (2)
CB inhibition with hypocapnic normoxic
blood; and (3) CB stimulation with hyper-
capnic normoxic blood. In the steady-state
of each CB perfusion, fractional inspired
CO2 (F ICO2 ) was progressively increased
to stimulate central chemoreceptors and
changes in ventilation, diaphragm electro-
myography (EMG), blood gases and arterial
pressure were quantified.
The main finding of Smith et al. (2015)
was that the increase in the slope of
minute ventilation and inspiratory flow
rate vs. changes in central PCO2 was 2- to
4-fold greater when the isolated CB was
exposed to hypercapnia vs. hypocapnia, and
2-fold greater during normocapnia vs.
hypocania. Thus, specific CB stimulation
or inhibition by hypercapnia/hypocapnia,
while central chemoreceptors were
stimulated by increased F ICO2 , resulted
in hyperadditive interaction. Noteworthy,
the present findings corroborate those
previously reported by Dr Dempsey’s lab
(Blain et al. 2010) using the same dog
preparation. Earlier, authors demonstrated
that inhibition or stimulation of vascularly
isolated CB with changes in O2 levels also
affected the magnitude of the ventilatory
response to central hypercapnia in a
hyperadditive fashion. Therefore, based
on current and previous findings, Smith
et al. (2015) suggest that changes in PO2
and PCO2 at the CB have similar effects
on peripheral–central interaction for the
control of ventilation.
Results reported by Smith et al. (2015) are
unique, since they were obtained in intact,
unanaesthesized, awake animals, which is
probably the best method used so far to
translate results to spontaneously breathing
humans. Nevertheless, they should be
interpreted in light of some limitations.
One is the use of systemic hypercapnia,
which may not only stimulate central
chemoreceptors, but may directly modify
the activity of other receptors, such as
pulmonary stretch receptors, or even the
activity of neurons from the ‘central respira-
tory controller’, where supposedly all inputs
that regulate ventilation are integrated.
Unfortunately, it is impossible to exclusively
manipulate the central chemoreceptors in
intact, unanaesthesized and awake animals
without systemic effects. To avoid systemic
effects, Day & Wilson (2009), for example,
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have proposed a rat model that allows
independent perfusion of brainstem and
peripheral chemoreceptors. However, this
preparation has low applicability to humans
and its results have not been consistent with
others (Blain et al. 2010; Smith et al. 2015).
In addition, both Smith et al. (2015) and
Blain et al. (2010) reported hyperadditive
effects, but more ventilatory variables
were affected by changes in CB PO2 (i.e.
minute ventilation, tidal volume, breathing
frequency and diaphragm EMG) than CB
PCO2 (i.e.minute ventilationand inspiratory
flow rate). The preparation in both studies
was similar, but dogs were not the same,
which raises the following questions: is
peripheral–central chemoreflex synergism
more dependent on the O2 level at the
CB than the CO2 level? This is plausible,
since the CB seems to be more responsive
to hypoxia than hypercapnia. However,
this complex question requires further
investigation and possible differences in
operating ranges of the CB for PO2 and PCO2
should be considered. Alternatively, are the
quantitative differences between Smith et al.
(2015) andBlain et al. (2010)only attributed
to data variability? These questions could
be answered by manipulating CO2 and
O2 using the same dogs in a single
study.
Even with the aforementioned limitations,
results from Smith et al. (2015) and
Blain et al. (2010) were consistent with
some previous studies that used different
models/species. For instance, dogs, goats,
ponies and humans showhypoventilation at
rest and reduced responsiveness to systemic
normoxic or hyperoxic hypercapnia within
few days after bilateral CB denervation.
Altogether, these findings support the
hyperadditive interaction. Then, assuming
that the interaction is indeed hyper-
additive, many interesting questions arise
whose answers may further confirm the
nature of the interaction and widen its
practical application to human physio-
logy and pathophysiology. For example,
the existing literature supports that
peripheral chemoreceptors are sensitized
during exercise (Stickland et al. 2007; cited
by Dempsey & Smith, 2014). Thus, is the
interaction evenmore hyperadditive during
exercise than rest? Furthermore, results
reported by Smith et al. (2015) and Blain
et al. (2010)were obtained via acute changes
in regional and/or systemic levels of O2 and
CO2 in healthy animals. Then, how does
the peripheral–central chemoreflex inter-
action work for the control of ventilation
in animals/humans with chronic hyper-
capnia/hypoxaemia? This is a complex issue,
which probably depends on the underlying
disease. For example, it is well established
that both central and peripheral chemo-
reflex sensitivity is augmented in CHF
and OSA, which contributes to ventilatory
and autonomic abnormalities (Kara et al.
2003). Accordingly, it would be relevant
to know if the peripheral–central chemo-
receptors exhibit a similar synergism to
that observed in healthy dogs and how this
evolved during the natural history of these
diseases. Patients with advanced COPD,
in turn, commonly show chronic hyper-
capnia and may have blunted central CO2
sensitivity. Thus, is the peripheral–central
chemoreflex interaction attenuated in these
patients with COPD? Even more complex,
but also scientifically exciting, is dissecting
the peripheral–central chemoreflex inter-
action in patients with overlapping diseases,
such as CHF and COPD. Such a condition is
relatively frequent and leads to catastrophic
symptoms, quality of life and prognosis.
In conclusion, Smith et al. (2015)
demonstrated that central chemo-
receptor sensitivity to hypercapnia in
non-anaesthetized intact dogs is dependent
on CB afferent activity, leading to hyper-
additive peripheral–central interaction for
the control of ventilation. So what comes
next? Future studies should keep looking
at this physiological phenomenon under
an integrative perspective, to advance
knowledge about its contribution to
cardiorespiratory control in health and
disease, under varied physiological states,
including rest, exercise and sleep. Hopefully,
this will culminate with treatments that can
hit involved mechanisms right on target
to prevent or alleviate cardiorespiratory
diseases.
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